Gene Therapy Market Size, Global Trends, Top Share, Forecast to 2031

Download Free Sample

Market Segmentation

Gene Therapy Market, By Type (2019-2031)

Gene silencing
Cell replacement
Gene augmentation
Other therapies

Gene Therapy Market, By Vector (2019-2031)

Viral vectors
Non-Viral vectors

Gene Therapy Market, By Therapeutic area (2019-2031)

Neurology
Oncology
Hepatology
Other therapeutic areas

Gene Therapy Market, By Delivery method (2019-2031)

In Vivo
Ex Vivo

Gene Therapy Market, By Route of administration (2019-2031)

Intravenous
Other routes of administration

Gene Therapy Market, By Indication (2019-2031)

Cancer
Metabolic Disorders
Eye Disorders
Spinal Muscular Atrophy
Other Indications

Gene Therapy Market, By Technology (2019-2031)

Adeno Virus Vector
Adeno-associated Virus Vector
Lentiviral Vector
Retroviral Vector
Herpes Virus Vector
Other Technologies

Regional Gene Therapy Market

North America
1. North America Gene Therapy Market, By Type
  1. Gene silencing
  2. Cell replacement
  3. Gene augmentation
  4. Other therapies
2. North America Gene Therapy Market, By Vector
  1. Viral vectors
  2. Non-Viral vectors
3. North America Gene Therapy Market, By Therapeutic area
  1. Neurology
  2. Oncology
  3. Hepatology
  4. Other therapeutic areas
4. North America Gene Therapy Market, By Delivery method
  1. In Vivo
  2. Ex Vivo
5. North America Gene Therapy Market, By Route of administration
  1. Intravenous
  2. Other routes of administration
6. North America Gene Therapy Market, By Indication
  1. Cancer
  2. Metabolic Disorders
  3. Eye Disorders
  4. Spinal Muscular Atrophy
  5. Other Indications
7. North America Gene Therapy Market, By Technology
  1. Adeno Virus Vector
  2. Adeno-associated Virus Vector
  3. Lentiviral Vector
  4. Retroviral Vector
  5. Herpes Virus Vector
  6. Other Technologies
8. U.S.
  1. U.S. Gene Therapy Market, By Type
    1. Gene silencing
    2. Cell replacement
    3. Gene augmentation
    4. Other therapies
  2. U.S. Gene Therapy Market, By Vector
    1. Viral vectors
    2. Non-Viral vectors
  3. U.S. Gene Therapy Market, By Therapeutic area
    1. Neurology
    2. Oncology
    3. Hepatology
    4. Other therapeutic areas
  4. U.S. Gene Therapy Market, By Delivery method
    1. In Vivo
    2. Ex Vivo
  5. U.S. Gene Therapy Market, By Route of administration
    1. Intravenous
    2. Other routes of administration
  6. U.S. Gene Therapy Market, By Indication
    1. Cancer
    2. Metabolic Disorders
    3. Eye Disorders
    4. Spinal Muscular Atrophy
    5. Other Indications
  7. U.S. Gene Therapy Market, By Technology
    1. Adeno Virus Vector
    2. Adeno-associated Virus Vector
    3. Lentiviral Vector
    4. Retroviral Vector
    5. Herpes Virus Vector
    6. Other Technologies
9. Canada
Europe
1. Europe Gene Therapy Market, By Type
  1. Gene silencing
  2. Cell replacement
  3. Gene augmentation
  4. Other therapies
2. Europe Gene Therapy Market, By Vector
  1. Viral vectors
  2. Non-Viral vectors
3. Europe Gene Therapy Market, By Therapeutic area
  1. Neurology
  2. Oncology
  3. Hepatology
  4. Other therapeutic areas
4. Europe Gene Therapy Market, By Delivery method
  1. In Vivo
  2. Ex Vivo
5. Europe Gene Therapy Market, By Route of administration
  1. Intravenous
  2. Other routes of administration
6. Europe Gene Therapy Market, By Indication
  1. Cancer
  2. Metabolic Disorders
  3. Eye Disorders
  4. Spinal Muscular Atrophy
  5. Other Indications
7. Europe Gene Therapy Market, By Technology
  1. Adeno Virus Vector
  2. Adeno-associated Virus Vector
  3. Lentiviral Vector
  4. Retroviral Vector
  5. Herpes Virus Vector
  6. Other Technologies
8. U.K.
  1. U.K. Gene Therapy Market, By Type
    1. Gene silencing
    2. Cell replacement
    3. Gene augmentation
    4. Other therapies
  2. U.K. Gene Therapy Market, By Vector
    1. Viral vectors
    2. Non-Viral vectors
  3. U.K. Gene Therapy Market, By Therapeutic area
    1. Neurology
    2. Oncology
    3. Hepatology
    4. Other therapeutic areas
  4. U.K. Gene Therapy Market, By Delivery method
    1. In Vivo
    2. Ex Vivo
  5. U.K. Gene Therapy Market, By Route of administration
    1. Intravenous
    2. Other routes of administration
  6. U.K. Gene Therapy Market, By Indication
    1. Cancer
    2. Metabolic Disorders
    3. Eye Disorders
    4. Spinal Muscular Atrophy
    5. Other Indications
  7. U.K. Gene Therapy Market, By Technology
    1. Adeno Virus Vector
    2. Adeno-associated Virus Vector
    3. Lentiviral Vector
    4. Retroviral Vector
    5. Herpes Virus Vector
    6. Other Technologies
9. Germany
10. France
11. Spain
12. Italy
13. Russia
14. Nordic
15. Benelux
16. Rest of Europe
APAC
1. APAC Gene Therapy Market, By Type
  1. Gene silencing
  2. Cell replacement
  3. Gene augmentation
  4. Other therapies
2. APAC Gene Therapy Market, By Vector
  1. Viral vectors
  2. Non-Viral vectors
3. APAC Gene Therapy Market, By Therapeutic area
  1. Neurology
  2. Oncology
  3. Hepatology
  4. Other therapeutic areas
4. APAC Gene Therapy Market, By Delivery method
  1. In Vivo
  2. Ex Vivo
5. APAC Gene Therapy Market, By Route of administration
  1. Intravenous
  2. Other routes of administration
6. APAC Gene Therapy Market, By Indication
  1. Cancer
  2. Metabolic Disorders
  3. Eye Disorders
  4. Spinal Muscular Atrophy
  5. Other Indications
7. APAC Gene Therapy Market, By Technology
  1. Adeno Virus Vector
  2. Adeno-associated Virus Vector
  3. Lentiviral Vector
  4. Retroviral Vector
  5. Herpes Virus Vector
  6. Other Technologies
8. China
  1. China Gene Therapy Market, By Type
    1. Gene silencing
    2. Cell replacement
    3. Gene augmentation
    4. Other therapies
  2. China Gene Therapy Market, By Vector
    1. Viral vectors
    2. Non-Viral vectors
  3. China Gene Therapy Market, By Therapeutic area
    1. Neurology
    2. Oncology
    3. Hepatology
    4. Other therapeutic areas
  4. China Gene Therapy Market, By Delivery method
    1. In Vivo
    2. Ex Vivo
  5. China Gene Therapy Market, By Route of administration
    1. Intravenous
    2. Other routes of administration
  6. China Gene Therapy Market, By Indication
    1. Cancer
    2. Metabolic Disorders
    3. Eye Disorders
    4. Spinal Muscular Atrophy
    5. Other Indications
  7. China Gene Therapy Market, By Technology
    1. Adeno Virus Vector
    2. Adeno-associated Virus Vector
    3. Lentiviral Vector
    4. Retroviral Vector
    5. Herpes Virus Vector
    6. Other Technologies
9. Korea
10. Japan
11. India
12. Australia
13. Singapore
14. Taiwan
15. South East Asia
16. Rest of Asia-Pacific
Middle East and Africa
1. Middle East and Africa Gene Therapy Market, By Type
  1. Gene silencing
  2. Cell replacement
  3. Gene augmentation
  4. Other therapies
2. Middle East and Africa Gene Therapy Market, By Vector
  1. Viral vectors
  2. Non-Viral vectors
3. Middle East and Africa Gene Therapy Market, By Therapeutic area
  1. Neurology
  2. Oncology
  3. Hepatology
  4. Other therapeutic areas
4. Middle East and Africa Gene Therapy Market, By Delivery method
  1. In Vivo
  2. Ex Vivo
5. Middle East and Africa Gene Therapy Market, By Route of administration
  1. Intravenous
  2. Other routes of administration
6. Middle East and Africa Gene Therapy Market, By Indication
  1. Cancer
  2. Metabolic Disorders
  3. Eye Disorders
  4. Spinal Muscular Atrophy
  5. Other Indications
7. Middle East and Africa Gene Therapy Market, By Technology
  1. Adeno Virus Vector
  2. Adeno-associated Virus Vector
  3. Lentiviral Vector
  4. Retroviral Vector
  5. Herpes Virus Vector
  6. Other Technologies
8. UAE
  1. UAE Gene Therapy Market, By Type
    1. Gene silencing
    2. Cell replacement
    3. Gene augmentation
    4. Other therapies
  2. UAE Gene Therapy Market, By Vector
    1. Viral vectors
    2. Non-Viral vectors
  3. UAE Gene Therapy Market, By Therapeutic area
    1. Neurology
    2. Oncology
    3. Hepatology
    4. Other therapeutic areas
  4. UAE Gene Therapy Market, By Delivery method
    1. In Vivo
    2. Ex Vivo
  5. UAE Gene Therapy Market, By Route of administration
    1. Intravenous
    2. Other routes of administration
  6. UAE Gene Therapy Market, By Indication
    1. Cancer
    2. Metabolic Disorders
    3. Eye Disorders
    4. Spinal Muscular Atrophy
    5. Other Indications
  7. UAE Gene Therapy Market, By Technology
    1. Adeno Virus Vector
    2. Adeno-associated Virus Vector
    3. Lentiviral Vector
    4. Retroviral Vector
    5. Herpes Virus Vector
    6. Other Technologies
9. Turkey
10. Saudi Arabia
11. South Africa
12. Egypt
13. Nigeria
14. The rest of MEA
LATAM
1. LATAM Gene Therapy Market, By Type
  1. Gene silencing
  2. Cell replacement
  3. Gene augmentation
  4. Other therapies
2. LATAM Gene Therapy Market, By Vector
  1. Viral vectors
  2. Non-Viral vectors
3. LATAM Gene Therapy Market, By Therapeutic area
  1. Neurology
  2. Oncology
  3. Hepatology
  4. Other therapeutic areas
4. LATAM Gene Therapy Market, By Delivery method
  1. In Vivo
  2. Ex Vivo
5. LATAM Gene Therapy Market, By Route of administration
  1. Intravenous
  2. Other routes of administration
6. LATAM Gene Therapy Market, By Indication
  1. Cancer
  2. Metabolic Disorders
  3. Eye Disorders
  4. Spinal Muscular Atrophy
  5. Other Indications
7. LATAM Gene Therapy Market, By Technology
  1. Adeno Virus Vector
  2. Adeno-associated Virus Vector
  3. Lentiviral Vector
  4. Retroviral Vector
  5. Herpes Virus Vector
  6. Other Technologies
8. Brazil
  1. Brazil Gene Therapy Market, By Type
    1. Gene silencing
    2. Cell replacement
    3. Gene augmentation
    4. Other therapies
  2. Brazil Gene Therapy Market, By Vector
    1. Viral vectors
    2. Non-Viral vectors
  3. Brazil Gene Therapy Market, By Therapeutic area
    1. Neurology
    2. Oncology
    3. Hepatology
    4. Other therapeutic areas
  4. Brazil Gene Therapy Market, By Delivery method
    1. In Vivo
    2. Ex Vivo
  5. Brazil Gene Therapy Market, By Route of administration
    1. Intravenous
    2. Other routes of administration
  6. Brazil Gene Therapy Market, By Indication
    1. Cancer
    2. Metabolic Disorders
    3. Eye Disorders
    4. Spinal Muscular Atrophy
    5. Other Indications
  7. Brazil Gene Therapy Market, By Technology
    1. Adeno Virus Vector
    2. Adeno-associated Virus Vector
    3. Lentiviral Vector
    4. Retroviral Vector
    5. Herpes Virus Vector
    6. Other Technologies
9. Mexico
10. Argentina
11. Chile
12. Colombia
13. Rest of LATAM

Related Reports

Cell and Gene Therapy Market

Global Report

Cell and Gene Therapy Market Size The global cell and gene therapy market size was valued at USD 30.27 billion in 2024 and is projected to reach from USD 37.14 billion in 2025 to USD 190.82 billion by 2033, expanding at a CAGR of 22.7% from 2025 to

Buy Now

Electrotherapy Market

Global Report

Electrotherapy Market Size The global electrotherapy market size was valued at USD 1265.85 million in 2024 and is projected to reach from USD 1331.67 million in 2025 to USD 1997.67 million by 2033, growing at a CAGR of 5.20% during the forecast peri

Buy Now

Purchase Benefits

Eligible for a free updated report next year
Completely customizable scope
30% discount on your next purchase
Dedicated account manager
Query resolution within 24 hours
Permission to print the report

Market Segmentation

Related Reports

Purchase Benefits

We are featured on :

Sample Details